ArticleInvestigational new drugs2011

LYP, a novel bestatin derivative, inhibits cell growth and suppresses APN/CD13 activity in human ovarian carcinoma cells more potently than bestatin.

Jian-Jun Gao et al.PubMed ↗Publisher ↗

No numbers read from the abstract.